Drug
Ciprodex
Ciprodex is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Phase Distribution
Ph phase_4
2
67%
Ph phase_3
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(2)
Detailed Status
Withdrawn2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (33.3%)
Phase 42 (66.7%)
Trials by Status
completed133%
withdrawn267%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_3
Comparative Efficacy and Safety of Ciprofloxacin 0.3% and Dexamethasone 0.1% in Acute Otitis Externa
NCT02216071
withdrawnphase_4
N-Acetylcysteine as an Adjunct for Refractory Chronic Suppurative Otitis Media
NCT00956748
withdrawnphase_4
Otiprio Versus Ciprodex Tympanostomy Tube Outcomes
NCT03347461
Clinical Trials (3)
Showing 3 of 3 trials
NCT02216071Phase 3
Comparative Efficacy and Safety of Ciprofloxacin 0.3% and Dexamethasone 0.1% in Acute Otitis Externa
NCT00956748Phase 4
N-Acetylcysteine as an Adjunct for Refractory Chronic Suppurative Otitis Media
NCT03347461Phase 4
Otiprio Versus Ciprodex Tympanostomy Tube Outcomes
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3